Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 November 2023 | Story Michelle Nöthling | Photo Andile Andries Ndlovu
Nelisiwe Vilakazi and Abigail Webb
Nelisiwe Vilakazi (Head of Department for Social Development: KZN) and Abigail Webb during the ASASWEI International Conference and Awards 2023.

In a remarkable feat, Abigail ‘Zinhle’ Webb has clinched the prestigious Best Student Achievement Award from the Association of South African Social Work Education Institutions (ASASWEI), standing out among the nation's top-ranking students. This accolade, beyond acknowledging academic prowess, demands a notable contribution to the community – a criterion Abigail undeniably fulfils.

Elizabeth Msadu, Assistant Director of Student Counselling and Development and Abigail’s supervisor during her final year in Social Work at the University of the Free State (UFS) commends Abigail for  “her passion, integrity, high standards, and perhaps most of all, how selflessly she strives to improve the lives of the students around her.” 

Community engagement: breaking taboos

Abigail's success is not confined to academic excellence; her proactive approach to community issues is equally commendable. Observing the free condom container in her residence bathroom one day, she questioned the absence of support for female students regarding sanitary products. She found that “there is still immense shame around vaginal health.” This led to the initiation of workshops and the #comebleedwithusperiod social media challenge, normalising discussions around women’s menstrual health.

During her tenure on Akasia’s Residence Committee and as Prime this year, Abigail identified a reluctance among female students to assume leadership roles. Questioning this disparity, she launched a project aimed at addressing female apprehension surrounding leadership and failure. Through this initiative, Abigail empowered female students to embrace leadership positions and overcome societal expectations. 

Future plans: a commitment to growth

While Abigail is drawn to child and family services, and adoption work, she plans to gain practical experience before pursuing a Master’s degree. Inspired by the researchers she encountered at the ASASWEI conference and award ceremony, she expresses her newfound interest in research, envisioning a future where she actively contributes to the field.

Time well spent: reflecting on four years

Reflecting on her proudest achievements she said, “I think I’m most proud that I spent my time well. I lived to my fullest during my four years of study.” Recognising the crucial role of belonging in student success, she emphasises the significance of forming connections. From a shy, first-year student with a stutter, Abigail evolved into a dynamic force, dedicated to connecting and serving the community. 

As Abigail approaches the end of her studies, she acknowledges the uncertainty of the next step but asserts with confidence, “It’s going to be okay. I’m going to be okay.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept